Which Tools Better Predict Fall Risk in Parkinson's Disease: A Comparative Study of Objective, Self-Reported, and Functional Balance Assessment Trial N/A Recruiting Aug. 28, 2025
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis Trial Phase 4 Recruiting Aug. 27, 2025
Neurophysiology of Locomotor Adaptation and Freezing of Gait in Parkinson's Disease Trial N/A Recruiting Aug. 26, 2025
Self-controlled Practice on Motor Learning and Motivation in Parkinson's Disease Trial N/A Recruiting Aug. 26, 2025
Remote Mental Practice for Freezing of Gait in Parkinson's Disease Trial N/A Recruiting Aug. 26, 2025
Collection of Digital Parameters From Parts of the Neurological Examination Using an Eye Tracker Trial N/A Not yet recruiting Aug. 25, 2025
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease Trial Phase 4 Recruiting Aug. 23, 2025
Deciphering the Mechanisms of Central BP Regulation in Patients With PD Associated With Orthostatic Hypotension Trial N/A Not yet recruiting Aug. 23, 2025
Effect of a Vibrating Therapy Ball on Tremor and Daily Activities in Patients With Different Tremor Syndroms Trial N/A Recruiting Aug. 20, 2025
Opioidergic and Noradrenergic Systems in Central Parkisonian Pain Trial N/A Not yet recruiting Aug. 16, 2025
Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease Trial N/A Recruiting Aug. 14, 2025
A Study to Evaluate Feasibility, Safety, and Clinical Responses of Implanting Autologous Peripheral Nerve Tissue Into the Brain for Non-motor or Motor Symptoms in Patients With Parkinson's Disease Undergoing DBS Surgery Trial Phase 1 Recruiting Aug. 13, 2025
Home-based Gait and Balance Training in Patients With Movement Disorders Trial N/A Recruiting Aug. 12, 2025
SegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease Trial N/A Recruiting Aug. 12, 2025
Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases Trial Phase 4 Recruiting Aug. 11, 2025